Selected article for: "dysphagia high risk and high risk"
Author: da Cunha, Gilmara Franco; de Souza, Fernando Henrique Carlos; Levy-Neto, Maurício; Shinjo, Samuel Katsuyuki
Title: Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis
  • Document date: 2013_5_23
    • ID: s9mqzqu4_10
    Snippet: All of the patients were first started on corticosteroids (prednisone 1 mg/kg/day, administered orally), which were tapered gradually according to clinical and laboratory stability. In cases of high disease severity (dysphagia with risk of aspiration pneumonia, cutaneous vasculitis, or being refractory to oral corticosteroids), intravenous corticosteroids were administered (methyl prednisolone 1 g/day for three consecutive days). The following dr.....
    Document: All of the patients were first started on corticosteroids (prednisone 1 mg/kg/day, administered orally), which were tapered gradually according to clinical and laboratory stability. In cases of high disease severity (dysphagia with risk of aspiration pneumonia, cutaneous vasculitis, or being refractory to oral corticosteroids), intravenous corticosteroids were administered (methyl prednisolone 1 g/day for three consecutive days). The following drugs were used alone or in combination for corticosteroid sparing: azathioprine (2-3 mg/kg/day), methotrexate (20-25 mg/week), cyclosporine (2-3 mg/kg/day), mycophenolate mofetil (2-3 g/day), leflunomide (20 mg/day), cyclophosphamide (0.5-1.0 g/m 2 of body surface), intravenous human immunoglobulin (1 g/ kg/day for two consecutive days) and chloroquine diphosphate (3-4 mg/kg/day).

    Search related documents:
    Co phrase search for related documents
    • body surface and consecutive day: 1
    • body surface and disease severity: 1, 2, 3
    • body surface and kg day: 1, 2, 3
    • body surface and mg kg day: 1, 2
    • body surface and mg week: 1
    • consecutive day and disease severity: 1, 2, 3, 4, 5, 6, 7
    • consecutive day and human immunoglobulin: 1
    • consecutive day and kg day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • consecutive day and methyl prednisolone: 1
    • consecutive day and mg kg day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • consecutive day and mg week: 1
    • corticosteroid sparing and oral corticosteroid: 1, 2
    • cutaneous vasculitis and disease severity: 1